Opinion

The Jefferies Healthcare Temperature Check report is now in its third edition and published to coincide with the 11th annual Global Healthcare Conference which was held virtually. Over 500 responses from senior leaders in the sector responded for this year’s report, giving views on both the current state of the market and predictions for 2021. […]

Mike Rea is CEO of IDEA Pharma. Over the last 20 years he has worked on a range of successful new drug launches. He recently turned his hand to writing with the publication of his book Pharmaceutical Positioning. Lu Rahman found out more about this topic and why drug developers should be thinking about it […]

Richard Torbett, Chief Executive, ABPI says vaccines are one of our best hopes for eradicating COVID-19 and why the ABPI is launching a campaign to highlight this. “COVID-19 has put shone a spotlight on the pharmaceutical industry like never before. Millions of people all over the world are living under some form of restrictions.  The […]

By FRAME (Fund for the Replacement of Animals in Medical Experiments) CEO, Celean Camp, FRAME Alternatives Laboratory Director, Dr Andrew Bennett and FRAME Scientific Liaison Officer, Amy Beale. Animals remain the first choice for testing and research in drug discovery and development, despite scientific advances across a range of other methodologies, and some tightening of […]

Adrian van den Hoven, Director General, Medicines for Europe, looks at how COVID-19 has altered the way we consider EU pharmaceutical policy Adrian van den Hoven delivered the opening keynote address at the CPhI Festival of Pharma on how COVID-19 is changing the landscape of European pharmaceutical policy, primarily with regard to supply chain security. […]

Daniel Jamieson is the CEO and Founder of Biorelate, a biomedical curation company that aims to accelerate insight and innovation in drug discovery. Lu Rahman spoke to him about his vision for the business, how COVID-19 has affected the landscape and the technology behind his drug discovery success. Biorelate was founded in 2014 from scientific […]

What a time to be involved in drug discovery. While COVID-19 has of course created unprecedented conditions on a global scale, it has also highlighted the extent to which this sector offers depth of knowledge, skill and innovation. It is a pleasure to learn more about the market – both COVID and non-COVID – and […]

Lu Rahman speaks to key members of Metabolon on the company’s pioneering work in metabolomics including its innovative collaborations with DNAGenotek and the Institute for Systems Biology. “Metabolon has built an unrivalled global biochemical profiling platform capable of providing metabolite data of unsurpassed quality and coverage,” says Brian Keppler, PhD, Director, Discovery and Translational Sciences at […]

Dr Darrin M Disley, CEO of Mogrify, knows his way around a football field and will be speaking at Drug Discovery Digital. A serial biotech entrepreneur, Disley was once told he wasn’t good enough to study chemistry, so he momentarily chose football. Fast forward to October 2020, he will be giving the plenary keynote address […]

While everyone’s attention is focused on efforts to contain COVID-19, few probably noticed signs that the UK health system is about to undergo some major changes that will have an impact on both patients and the healthcare industry as early as next year. In preparation for the end of the Brexit transition period, the UK government […]